Drug Profile
TFC 039
Alternative Names: SBM TFC 039; TFC-039; Wangeliejin; WanpagliflozinLatest Information Update: 20 Jun 2022
Price :
$50
*
At a glance
- Originator Sirona Biochem
- Developer Sirona Biochem; Wanbang Biopharma
- Class Antihyperglycaemics; Carbohydrates; Obesity therapies
- Mechanism of Action Sodium-glucose transporter 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Diabetes mellitus
Highest Development Phases
- Phase I Type 2 diabetes mellitus
- Research Unspecified
- No development reported Obesity